Yoel Kloog

Ras and its signals diffuse through the cell on randomly moving nanoparticles.

Uri Ashery, Ofer Yizhar, O. Yizhar, 2006, Cancer research.

The Ras Inhibitor S-Trans, Trans-Farnesylthiosalicylic Acid Exerts Long-Lasting Neuroprotection in a Mouse Closed Head Injury Model

Anat Biegon, Esther Shohami, Alexander Alexandrovich, 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation

Y. Kloog, Roni Haklai, Yoel Kloog, 2001, Oncogene.

The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer.

B. Rotblat, Y. Kloog, Barak Rotblat, 2008, Methods in enzymology.

A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration.

Y. Kloog, L. Goldberg, Yoel Kloog, 2006, Cancer research.

Fluid-Flow Induced Wall Shear Stress and Epithelial Ovarian Cancer Peritoneal Spreading

David Elad, Uri Zaretsky, Y. Kloog, 2013, PloS one.

H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output

Sarah J. Plowman, Hong Liang, J. Hancock, 2010, PloS one.

K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3.

Tianhai Tian, Nicholas Ariotti, T. Tian, 2008, Cancer research.

Galectin-1 is a novel structural component and a major regulator of h-ras nanoclusters.

J. Hancock, Liron Belanis, S. Plowman, 2008, Molecular biology of the cell.